Altace, Ramipril News

From the Bioengineering and Chronobiology Laboratories, University of Vigo, Campus Universitario, Vigo, 36200 Spain.

By MARLEY SEAMAN Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock, getting access to a promising drug candidate pipeline and new markets.Watson of Morristown, N.J., said the combined company will have about $3 billion in annual revenue and do business in more than 20 ...

Wouldn't it be great if one pill could cure everything? While a pill to cure every illness known to man is still in the planning stages, a pill that could prevent a wide variety of chronic illnesses has been researched and is showing some promise.

Clinical studies have demonstrated a different effect on blood pressure of some angiotensin-converting enzyme inhibitors when administered in the morning versus the evening.

Your medic unit responds to a 45-year-old man with 30 minutes of rapid onset chest pain.

My blood pressure medicine was recently switched to Cozaar. After taking my pills this morning, my mouth and tongue swelled up so I could barely talk.

Reuters reports on a 2,053-patient, Indian clinical trial that evaluated a "polypill" containing low doses of three blood-pressure drugs from different classes -- thiazide, atenolol and ramipril -- as well as the statin cholesterol-lowering drug Zocor and aspirin.

New Delhi: Even as Ranbaxy's share price continued to tumble on Monday, the pharma company obtained it's third abbreviated new drug approval from US FDA since the start of the year, to manufacture and market ...

Drug-maker Ranbaxy Laboratories today said it has received approval from the US drug regulator to market and manufacture Ramipril, used in the treatment of cardiovascular diseases.

OBJECTIVE: To compare the effects of 2 levels of blood pressure control and 3 antihypertensive drug classes on glomerular filtration rate decline in hypertension.

Thousands of Canadians with high blood pressure are taking a combination of drugs that increases their risk of sudden cardiac death, kidney disease and other complications, the Heart and Stroke Foundation ...

Abstract CONTEXT: Incidence of end-stage renal disease due to hypertension has increased in recent decades, but the optimal strategy for treatment of hypertension to prevent renal failure is unknown, especially ...

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies.

The ACE inhibitor ramipril is effective in preventing recurrent episodes of atrial fibrillation that occur in the absence of hypertension or heart disease, physicians in Italy report.

I read in your column a while back that a person heard music after taking the antidepressant amitriptyline.